Target intelligence / Profile preview

CMT1A duplicated region transcript 15-like 2 pseudogene (ENSG00000267441)

Target
ENSG00000267441
Molecular classification
Pseudogene, Noncoding RNA pseudogene, Unprocessed/duplicated pseudogene
01

Overview

CMT1A duplicated region transcript 15-like 2 pseudogene (ENSG00000267441) is a pseudogene, defined as a genomic DNA sequence similar to a normal gene but nonfunctional due to disabling mutations or lack of regulatory elements. Pseudogenes can arise by gene duplication or retrotransposition; those termed "duplicated region" likely originate from gene duplication events. These loci do not encode functional protein products, but some may be transcribed into RNA and participate in regulatory functions at the RNA level, including acting as potential microRNA decoys. However, most pseudogenes—including this one—are not considered therapeutic targets, and no drugs or therapeutic interventions are directed toward them. There are no recognized safety concerns, biomarker uses, or clinical associations specific to this locus. ENSG00000267441 is a pseudogene, not a protein-coding gene or therapeutic target. It does not interact with drugs, is not linked to a defined biological function or disease, and has no known clinical relevance beyond its categorization as a noncoding genomic element.

02

Biological functions

Regulation of gene expression (possible, as some pseudogenes may act as decoys for microRNAs or regulators of paralogous genes, though not all do)None established at the protein level (most pseudogenes do not code for functional proteins)
03

Disease associations

Other (rarely, pseudogenes have been associated with regulatory roles in diseases, including cancer, but there is no specific evidence for this pseudogene)

Beyond the preview

Go deeper on CMT1A duplicated region transcript 15-like 2 pseudogene (ENSG00000267441).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMT1A duplicated region transcript 15-like 2 pseudogene (ENSG00000267441).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call